-transparent.png){kind=logo}
Addition of immunomodulating therapy with Thymalin, a thymus agent, to the multimodality therapy of burnt patients contributes to a rapid normalization of immunological parameters. The most marked immune response was observed 7-10 days after a therapy course initiated in the early periods of burn disease in patients with severely depressed T-system immunity and a high sensitivity to the drug. Inclusion of a donor blood leukomass transfusion course activates the cellular link of the immune system just after the treatment course, but fails to favour a stable normalization of thymus-dependent lymphocyte ratios.
Related Publications
L O Shkrob, and
T N Lukoianova, and
S M Vishnevskaia, and
Iu M Panova, and
Iu D Kashin
May 1985,
Vrachebnoe delo,
L O Shkrob, and
T N Lukoianova, and
S M Vishnevskaia, and
Iu M Panova, and
Iu D Kashin
July 1980,
Klinicheskaia meditsina,
L O Shkrob, and
T N Lukoianova, and
S M Vishnevskaia, and
Iu M Panova, and
Iu D Kashin
January 1995,
Vestnik otorinolaringologii,
L O Shkrob, and
T N Lukoianova, and
S M Vishnevskaia, and
Iu M Panova, and
Iu D Kashin
July 1972,
Klinicheskaia meditsina,
L O Shkrob, and
T N Lukoianova, and
S M Vishnevskaia, and
Iu M Panova, and
Iu D Kashin
July 1977,
Klinicheskaia meditsina,
L O Shkrob, and
T N Lukoianova, and
S M Vishnevskaia, and
Iu M Panova, and
Iu D Kashin
January 1990,
Sovetskaia meditsina,
L O Shkrob, and
T N Lukoianova, and
S M Vishnevskaia, and
Iu M Panova, and
Iu D Kashin
January 1969,
Surgical forum,
L O Shkrob, and
T N Lukoianova, and
S M Vishnevskaia, and
Iu M Panova, and
Iu D Kashin
January 1986,
Przeglad dermatologiczny,
L O Shkrob, and
T N Lukoianova, and
S M Vishnevskaia, and
Iu M Panova, and
Iu D Kashin
July 1995,
Nederlands tijdschrift voor geneeskunde,
L O Shkrob, and
T N Lukoianova, and
S M Vishnevskaia, and
Iu M Panova, and
Iu D Kashin
April 1988,
Gematologiia i transfuziologiia,
